Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Is Moderna a Bad-News Buy?
11:00am, Sunday, 06'th Nov 2022 The Motley Fool
Moderna is heading for a big transition.
Is Moderna a Bad-News Buy?
06:00am, Sunday, 06'th Nov 2022
Moderna is heading for a big transition.
3 Things You Need to Know About Moderna's Post-Pandemic Revenue
10:30am, Saturday, 05'th Nov 2022 The Motley Fool
Is the next phase of revenue growth just ahead?
3 Things You Need to Know About Moderna's Post-Pandemic Revenue
06:30am, Saturday, 05'th Nov 2022
Is the next phase of revenue growth just ahead?
Did Vaccine Stocks Just Get Their Last Boost?
10:17pm, Friday, 04'th Nov 2022 The Motley Fool
Some positive news sent their share prices higher, but biotech companies will need to find other ways to make money.
7 Cash-Rich Stocks to Buy for Peace of Mind
02:22pm, Friday, 04'th Nov 2022
Companies of all sizes appear to be hoarding cash for the much-discussed impending recession. If we do dive into a recession, cash-rich stocks will be more than prepared for whatever slowdown comes th
Moderna To 170? Plus This Analyst Slashes PT On Funko By 50%
01:41pm, Friday, 04'th Nov 2022 Benzinga
Morgan Stanley slashed the price target on Moderna, Inc. (NASDAQ: MRNA) from $175 to $170. Moderna shares fell 0.7% to trade at $146.49 on Friday.
Truist Securities lowered Funko, Inc. (NASDAQ: F
This Key Piece Of News Could Sparked BioNTech, Moderna — And Could Stoke Demand For Covid Boosters
12:58pm, Friday, 04'th Nov 2022
Covid vaccine stocks surged Friday after a new study suggested an added benefit of the updated omicron-targeting boosters. The post This Key Piece Of News Could Sparked BioNTech, Moderna — And Could
Is Moderna Stock A Buy Or A Sell As It Yo-Yos On An Influx Of Covid News?
12:34pm, Friday, 04'th Nov 2022
Is Moderna stock a buy or a sell after cutting its 2022 outlook for Covid vaccines just as Pfizer, BioNTech unveil promising booster news? The post Is Moderna Stock A Buy Or A Sell As It Yo-Yos On An
Moderna's Earnings Collapsed. Time to Sell?
11:47am, Friday, 04'th Nov 2022 The Motley Fool
This drugmaker's bottom line fell down a deep hole in the third quarter and investors want to know if it's time to run for the hills.
Moderna's Earnings Collapsed. Time to Sell?
07:47am, Friday, 04'th Nov 2022
This drugmaker's bottom line fell down a deep hole in the third quarter and investors want to know if it's time to run for the hills.
Moderna Inc. (MRNA) Q3 2022 Earnings Call Transcript
08:30pm, Thursday, 03'rd Nov 2022 The Motley Fool
MRNA earnings call for the period ending September 30, 2022.
U.S. stocks book 4-day losing streak ahead of jobs data as investors continue to weigh Powell remarks
07:25pm, Thursday, 03'rd Nov 2022 MarketWatch
U.S. stocks ended lower on Thursday as investors absorb Federal Reserve Chairman Jerome Powell's comments from a day earlier.
Gold Drops Over 1%; Moderna Reports Downbeat Q3 Results
06:31pm, Thursday, 03'rd Nov 2022 Benzinga
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday.
The Dow traded down 0.04% to 32,133.97 while the NASDAQ fell 1.06% to 10,413.
Moderna's (MRNA) Lags on Q3 Earnings, Lowers '22 Sales Outlook
05:29pm, Thursday, 03'rd Nov 2022 Zacks Investment Research
Moderna's (MRNA) third-quarter earnings miss expectations, while sales narrowly beat the mark. Shares declined in pre-market trading after management announced a guidance cut in COVID vaccine sales.
